Literature DB >> 2171622

Long-term sequelae of treatment for testicular germ cell tumours.

D Bissett1, L Kunkeler, L Zwanenburg, J Paul, C Gray, I R Swan, D J Kerr, S B Kaye.   

Abstract

Seventy-four patients previously treated in our department for germ cell tumour of the testis underwent a series of tests to determine the frequency of long-term therapeutic complications. All had received cisplatin-based chemotherapy as part of their treatment. There was a significant deterioration in renal function throughout the group. Eighteen (24%) had supine blood pressure greater than systolic 140 mmHg or diastolic 90 mmHg after treatment but hypertension did not correlate with renal impairment. Raynaud's phenomenon was common after chemotherapy (26/74) as was persistent sensory neuropathy (23/74). Although 34% had testosterone levels below the normal range, only six patients had a low free testosterone index with one testis still in situ; 18 patients have fathered children after chemotherapy. Approximately half of the patients completed a psychosexual questionnaire and some 30% of them admitted to sexual problems which they attributed to their treatment. Long-term sequelae of cisplatin-based chemotherapy for testicular malignancy are frequent and persistent, and follow-up of these patients should include prospective measurement of changes in blood pressure.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2171622      PMCID: PMC1971502          DOI: 10.1038/bjc.1990.350

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

Review 1.  Long-term complications of cisplatin-based chemotherapy for testis cancer.

Authors:  B J Roth; L H Einhorn; A Greist
Journal:  Semin Oncol       Date:  1988-08       Impact factor: 4.929

Review 2.  Late toxicities, long-term follow-up, less intensive treatment: leading issues in the therapy of testis cancer.

Authors:  P W Kantoff; M B Garnick
Journal:  J Clin Oncol       Date:  1988-08       Impact factor: 44.544

3.  The late effects of cis-platinum on renal function.

Authors:  C R Hamilton; J M Bliss; A Horwich
Journal:  Eur J Cancer Clin Oncol       Date:  1989-02

4.  On the misdiagnoses resulting from incorrect use of masking.

Authors:  R R Coles; V M Priede
Journal:  J Laryngol Otol       Date:  1970-01       Impact factor: 1.469

5.  Some effects of combination chemotherapy with cis-platinum on renal function in patients with nonseminomatous testicular carcinoma.

Authors:  S Meijer; D T Sleijfer; N H Mulder; W J Sluiter; J Marrink; H S Koops; T M Brouwers; J Oldhoff; G K van der Hem; E Mandema
Journal:  Cancer       Date:  1983-06-01       Impact factor: 6.860

6.  Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies.

Authors:  S W Thompson; L E Davis; M Kornfeld; R D Hilgers; J C Standefer
Journal:  Cancer       Date:  1984-10-01       Impact factor: 6.860

7.  Raynaud's phenomenon: a common toxicity after combination chemotherapy for testicular cancer.

Authors:  N J Vogelzang; G J Bosl; K Johnson; B J Kennedy
Journal:  Ann Intern Med       Date:  1981-09       Impact factor: 25.391

8.  Ototoxicity of cis-diamminedichloroplatinum (II): influence of dose, schedule and mode of administration.

Authors:  J B Vermorken; T S Kapteijn; A A Hart; H M Pinedo
Journal:  Eur J Cancer Clin Oncol       Date:  1983-01

9.  Fertility after chemotherapy for testicular cancer.

Authors:  R E Drasga; L H Einhorn; S D Williams; D N Patel; E E Stevens
Journal:  J Clin Oncol       Date:  1983-03       Impact factor: 44.544

10.  Renal vascular lesions after chemotherapy with vinblastine, bleomycin, and cisplatin.

Authors:  R M Harrell; R Sibley; N J Vogelzang
Journal:  Am J Med       Date:  1982-09       Impact factor: 4.965

View more
  18 in total

Review 1.  Comparative tolerability of chemotherapy regimens for germ cell cancer.

Authors:  S Culine; J P Droz
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

Review 2.  Zebrafish Germ Cell Tumors.

Authors:  Angelica Sanchez; James F Amatruda
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

3.  A randomized trial comparing the nephrotoxicity of cisplatin/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors.

Authors:  J T Hartmann; L M Fels; S Knop; H Stolt; L Kanz; C Bokemeyer
Journal:  Invest New Drugs       Date:  2000-08       Impact factor: 3.850

Review 4.  Complications associated with chemotherapy in testicular cancer management.

Authors:  Chunkit Fung; David J Vaughn
Journal:  Nat Rev Urol       Date:  2011-03-15       Impact factor: 14.432

Review 5.  Comparative adverse effect profiles of platinum drugs.

Authors:  M J McKeage
Journal:  Drug Saf       Date:  1995-10       Impact factor: 5.606

Review 6.  Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics.

Authors:  Lois B Travis; Sophie D Fossa; Howard D Sesso; Robert D Frisina; David N Herrmann; Clair J Beard; Darren R Feldman; Lance C Pagliaro; Robert C Miller; David J Vaughn; Lawrence H Einhorn; Nancy J Cox; M Eileen Dolan
Journal:  J Natl Cancer Inst       Date:  2014-03-12       Impact factor: 13.506

7.  Chemotherapy-induced ovarian failure as a prototype for acute vascular toxicity.

Authors:  Irit Ben-Aharon; Israel Meizner; Tal Granot; Shiri Uri; Noa Hasky; Shulamith Rizel; Rinat Yerushalmi; Aaron Sulkes; Salomon M Stemmer
Journal:  Oncologist       Date:  2012-09-06

8.  Accelerated BEP: a phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour.

Authors:  Y Rimmer; J Chester; J Joffe; D Stark; J Shamash; T Powles; J White; J Wason; D Parashar; G Armstrong; D Mazhar; M V Williams
Journal:  Br J Cancer       Date:  2011-08-16       Impact factor: 7.640

9.  Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors.

Authors:  Marianne Brydøy; Jan Oldenburg; Olbjørn Klepp; Roy M Bremnes; Erik A Wist; Tore Wentzel-Larsen; Erik R Hauge; Olav Dahl; Sophie D Fosså
Journal:  J Natl Cancer Inst       Date:  2009-12-16       Impact factor: 13.506

10.  Chemotherapy refractory testicular germ cell tumor is associated with a variant in Armadillo Repeat gene deleted in Velco-Cardio-Facial syndrome (ARVCF).

Authors:  Chunkit Fung; David J Vaughn; Nandita Mitra; Stephanie L Ciosek; Saran Vardhanabhuti; Katherine L Nathanson; Peter A Kanetsky
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-13       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.